Clinical Trial Update: A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A six-week Phase 4 trial compares the efficacy and safety of tiotropium plus formoterol against salmeterol plus fluticasone in chronic obstructive pulmonary dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Flovent (fluticasone propionate)
• Foradil (formoterol)
• Serevent (salmeterol)
• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED